- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04694651
Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt
A National Survey of Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt
The COVID-19 pandemic is expected to remain as a public health threat and economic burden all over the world. The available proposed vaccines are still lacking large randomized controlled trials testing its efficacy and safety. Thus, the acceptance of vaccination between citizens as well as healthcare workers is not guaranteed. As the vaccine is starting to be distributed the acceptance of healthcare givers should be measured as they are usually the front line facing the problem and they have a responsibility to explain the need of immunization to the rest of population.
Strategies to enhance the acceptance and trust of the available vaccines may be needed.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 71111
- Recruiting
- AssiutU
-
Contact:
- Aliae Mohamed-Hussein, MD
- Phone Number: 882413711
- Email: massah_99@yahoo.com
-
Assiut, Egypt, 71515
- Recruiting
- Aliae AR Mohamed-Hussein
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Participants were recruited by Consensus Strategies through online survey to avoid coverage bias.
Doctors, nurses, laboratory workers and radiology technicians were included
Description
Inclusion Criteria: Healthcare workers
-
Exclusion Criteria:
- None healthcare workers
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure frequency of acceptance of vaccination
Time Frame: 6 months
|
number of healthcare worker agreeing to take the vaccine
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Describe causes of refusal of vaccination
Time Frame: 6 months
|
answer a questionnaire of the causes of avoidance of vaccine
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AssiutU18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted